vs

Side-by-side financial comparison of Acadia Healthcare Company, Inc. (ACHC) and Matador Resources Co (MTDR). Click either name above to swap in a different company.

Acadia Healthcare Company, Inc. is the larger business by last-quarter revenue ($829.0M vs $809.5M, roughly 1.0× Matador Resources Co). Matador Resources Co runs the higher net margin — 23.8% vs 0.5%, a 23.2% gap on every dollar of revenue. On growth, Acadia Healthcare Company, Inc. posted the faster year-over-year revenue change (7.5% vs -17.2%). Over the past eight quarters, Acadia Healthcare Company, Inc.'s revenue compounded faster (2.0% CAGR vs 1.5%).

Acadia Healthcare Company, Inc. is an American provider of for-profit behavioral healthcare services. It operates a network of over 225 facilities across the United States and Puerto Rico.

Matador Resources Co is an independent energy firm engaged in the exploration, development, production and acquisition of oil, natural gas, and natural gas liquids. Its core operations are in major U.S. onshore resource basins, primarily serving North American energy markets.

ACHC vs MTDR — Head-to-Head

Bigger by revenue
ACHC
ACHC
1.0× larger
ACHC
$829.0M
$809.5M
MTDR
Growing faster (revenue YoY)
ACHC
ACHC
+24.8% gap
ACHC
7.5%
-17.2%
MTDR
Higher net margin
MTDR
MTDR
23.2% more per $
MTDR
23.8%
0.5%
ACHC
Faster 2-yr revenue CAGR
ACHC
ACHC
Annualised
ACHC
2.0%
1.5%
MTDR

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
ACHC
ACHC
MTDR
MTDR
Revenue
$829.0M
$809.5M
Net Profit
$4.5M
$192.5M
Gross Margin
Operating Margin
30.0%
Net Margin
0.5%
23.8%
Revenue YoY
7.5%
-17.2%
Net Profit YoY
-50.8%
-10.2%
EPS (diluted)
$0.05
$1.54

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ACHC
ACHC
MTDR
MTDR
Q1 26
$829.0M
Q4 25
$821.5M
$809.5M
Q3 25
$851.6M
$915.1M
Q2 25
$869.2M
$925.7M
Q1 25
$770.5M
$1.0B
Q4 24
$774.2M
$978.3M
Q3 24
$815.6M
$860.1M
Q2 24
$796.0M
$855.2M
Net Profit
ACHC
ACHC
MTDR
MTDR
Q1 26
$4.5M
Q4 25
$-1.2B
$192.5M
Q3 25
$36.2M
$176.4M
Q2 25
$30.1M
$150.2M
Q1 25
$8.4M
$240.1M
Q4 24
$32.6M
$214.5M
Q3 24
$68.1M
$248.3M
Q2 24
$78.5M
$228.8M
Operating Margin
ACHC
ACHC
MTDR
MTDR
Q1 26
Q4 25
-142.4%
30.0%
Q3 25
4.7%
33.4%
Q2 25
5.8%
31.2%
Q1 25
1.7%
38.7%
Q4 24
4.9%
36.8%
Q3 24
12.1%
45.6%
Q2 24
13.4%
42.5%
Net Margin
ACHC
ACHC
MTDR
MTDR
Q1 26
0.5%
Q4 25
-143.3%
23.8%
Q3 25
4.3%
19.3%
Q2 25
3.5%
16.2%
Q1 25
1.1%
23.9%
Q4 24
4.2%
21.9%
Q3 24
8.4%
28.9%
Q2 24
9.9%
26.8%
EPS (diluted)
ACHC
ACHC
MTDR
MTDR
Q1 26
$0.05
Q4 25
$-12.98
$1.54
Q3 25
$0.40
$1.42
Q2 25
$0.33
$1.21
Q1 25
$0.09
$1.92
Q4 24
$0.36
$1.71
Q3 24
$0.74
$1.99
Q2 24
$0.85
$1.83

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ACHC
ACHC
MTDR
MTDR
Cash + ST InvestmentsLiquidity on hand
$158.5M
$15.3M
Total DebtLower is stronger
$2.5B
$3.4B
Stockholders' EquityBook value
$2.0B
$5.7B
Total Assets
$5.5B
$11.7B
Debt / EquityLower = less leverage
1.29×
0.60×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ACHC
ACHC
MTDR
MTDR
Q1 26
$158.5M
Q4 25
$133.2M
$15.3M
Q3 25
$118.7M
$20.1M
Q2 25
$131.4M
$10.5M
Q1 25
$91.2M
$14.5M
Q4 24
$76.3M
$23.0M
Q3 24
$82.1M
$23.3M
Q2 24
$77.2M
$15.2M
Total Debt
ACHC
ACHC
MTDR
MTDR
Q1 26
$2.5B
Q4 25
$2.5B
$3.4B
Q3 25
$2.3B
$3.2B
Q2 25
$2.3B
$3.3B
Q1 25
$2.2B
$3.2B
Q4 24
$2.0B
$3.3B
Q3 24
$1.9B
Q2 24
$1.8B
Stockholders' Equity
ACHC
ACHC
MTDR
MTDR
Q1 26
$2.0B
Q4 25
$1.9B
$5.7B
Q3 25
$3.1B
$5.5B
Q2 25
$3.1B
$5.4B
Q1 25
$3.0B
$5.3B
Q4 24
$3.1B
$5.1B
Q3 24
$3.0B
$4.9B
Q2 24
$3.0B
$4.6B
Total Assets
ACHC
ACHC
MTDR
MTDR
Q1 26
$5.5B
Q4 25
$5.5B
$11.7B
Q3 25
$6.4B
$11.6B
Q2 25
$6.3B
$11.3B
Q1 25
$6.1B
$11.1B
Q4 24
$6.0B
$10.9B
Q3 24
$5.9B
$10.6B
Q2 24
$5.7B
$8.5B
Debt / Equity
ACHC
ACHC
MTDR
MTDR
Q1 26
1.29×
Q4 25
1.28×
0.60×
Q3 25
0.74×
0.58×
Q2 25
0.74×
0.61×
Q1 25
0.72×
0.60×
Q4 24
0.64×
0.65×
Q3 24
0.62×
Q2 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ACHC
ACHC
MTDR
MTDR
Operating Cash FlowLast quarter
$61.5M
$474.4M
Free Cash FlowOCF − Capex
$8.1M
FCF MarginFCF / Revenue
1.0%
Capex IntensityCapex / Revenue
57.6%
Cash ConversionOCF / Net Profit
13.78×
2.46×
TTM Free Cash FlowTrailing 4 quarters
$269.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ACHC
ACHC
MTDR
MTDR
Q1 26
$61.5M
Q4 25
$-86.3M
$474.4M
Q3 25
$73.2M
$721.7M
Q2 25
$133.5M
$501.0M
Q1 25
$11.5M
$727.9M
Q4 24
$116.7M
$575.0M
Q3 24
$163.1M
$610.4M
Q2 24
$171.1M
$592.9M
Free Cash Flow
ACHC
ACHC
MTDR
MTDR
Q1 26
Q4 25
$-179.5M
$8.1M
Q3 25
$-63.0M
$78.3M
Q2 25
$-34.2M
$9.6M
Q1 25
$-163.2M
$173.6M
Q4 24
$-86.8M
$45.2M
Q3 24
$-27.1M
$-1.6B
Q2 24
$16.9M
$69.0M
FCF Margin
ACHC
ACHC
MTDR
MTDR
Q1 26
Q4 25
-21.8%
1.0%
Q3 25
-7.4%
8.6%
Q2 25
-3.9%
1.0%
Q1 25
-21.2%
17.3%
Q4 24
-11.2%
4.6%
Q3 24
-3.3%
-186.5%
Q2 24
2.1%
8.1%
Capex Intensity
ACHC
ACHC
MTDR
MTDR
Q1 26
Q4 25
11.3%
57.6%
Q3 25
16.0%
70.3%
Q2 25
19.3%
53.1%
Q1 25
22.7%
55.1%
Q4 24
26.3%
54.2%
Q3 24
23.3%
257.4%
Q2 24
19.4%
61.3%
Cash Conversion
ACHC
ACHC
MTDR
MTDR
Q1 26
13.78×
Q4 25
2.46×
Q3 25
2.02×
4.09×
Q2 25
4.43×
3.34×
Q1 25
1.37×
3.03×
Q4 24
3.58×
2.68×
Q3 24
2.39×
2.46×
Q2 24
2.18×
2.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ACHC
ACHC

Acute Inpatient Psychiatric Facilities$471.0M57%
Other$140.0M17%
Specialty Treatment Facilities$128.0M15%
Residential Treatment Facilities$90.0M11%

MTDR
MTDR

Oil And Gas$702.8M87%
Natural Gas Sales$61.3M8%
Natural Gas Midstream$45.4M6%

Related Comparisons